D.E. Shaw & Co’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$62.9M Sell
5,485,285
-602,077
-10% -$8.48M 0.04% 566
2025
Q4
$87.5M Buy
6,087,362
+4,500,503
+284% +$77.9M 0.05% 448
2025
Q3
$30M Buy
1,586,859
+676,161
+74% +$11.1M 0.02% 916
2025
Q2
$19.5M Buy
910,698
+615,207
+208% +$9.15M 0.01% 1050
2025
Q1
$3.87M Buy
295,491
+172,341
+140% +$2.56M ﹤0.01% 2091
2024
Q4
$1.66M Sell
123,150
-183,322
-60% -$2.95M ﹤0.01% 2868
2024
Q3
$6.5M Buy
306,472
+193,682
+172% +$3.49M 0.01% 1745
2024
Q2
$1.78M Sell
112,790
-194,201
-63% -$3.57M ﹤0.01% 2751
2024
Q1
$4.56M Sell
306,991
-276,582
-47% -$3.79M ﹤0.01% 1959
2023
Q4
$5.34M Buy
583,573
+225,949
+63% +$1.56M ﹤0.01% 1856
2023
Q3
$1.99M Sell
357,624
-483,641
-57% -$3.38M ﹤0.01% 2570
2023
Q2
$6.78M Buy
841,265
+400,221
+91% +$2.95M 0.01% 1645
2023
Q1
$2.88M Sell
441,044
-47,666
-10% -$195K ﹤0.01% 2410
2022
Q4
$1.2M Buy
488,710
+230,761
+89% +$721K ﹤0.01% 3310
2022
Q3
$1.29M Buy
+257,949
New +$1.51M ﹤0.01% 3393
2022
Q2
Sell
-13,926
Closed -$88.6K 5652
2022
Q1
$139K Buy
+13,926
New +$104K ﹤0.01% 4948

Other funds holding OSCR

D.E. Shaw & Co's OSCR Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Oscar Health (OSCR) stake by 9.9% in Q1 2026, selling an estimated $8.48M and leaving 5,485,285 shares worth $62.9M. The position accounts for 0.04% of the portfolio, ranked #566.

D.E. Shaw & Co first reported a position in OSCR in Q1 2022 and has held it in 16 quarters since. The position peaked at $87.5M in Q4 2025. 330 funds tracked by Wall St. Rank hold OSCR as of Q1 2026.

  • D.E. Shaw & Co held 5,485,285 shares of Oscar Health worth $62.9M as of Q1 2026.
  • D.E. Shaw & Co sold 602,077 Oscar Health shares in Q1 2026, an estimated $8.48M.
  • Oscar Health made up 0.04% of D.E. Shaw & Co's portfolio in Q1 2026, its #566 holding.
  • D.E. Shaw & Co first reported a position in Oscar Health in Q1 2022 and has held it in 16 quarters since.
  • D.E. Shaw & Co's Oscar Health position peaked at $87.5M in Q4 2025.
  • 330 funds tracked by Wall St. Rank held Oscar Health as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.